These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? Meurer LN; Slawson JG J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554 [No Abstract] [Full Text] [Related]
3. [Third-generation oral contraceptives--how big is the risk of venous thrombosis?]. Iversen OE Tidsskr Nor Laegeforen; 2004 Jun; 124(11):1521-2. PubMed ID: 15195157 [No Abstract] [Full Text] [Related]
4. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis. Griffin JP Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631 [No Abstract] [Full Text] [Related]
5. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. Kemmeren JM; Algra A; Grobbee DE BMJ; 2001 Jul; 323(7305):131-4. PubMed ID: 11463678 [TBL] [Abstract][Full Text] [Related]
6. [Sexual abstinence of thrombosis? Comment on the controversy regarding the "pill of the 3rd generation"]. Strobel E Fortschr Med; 1995 Nov; 113(33):18, 20. PubMed ID: 8575701 [No Abstract] [Full Text] [Related]
7. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis? Sapp AV; Lindbloom EJ J Fam Pract; 2001 Oct; 50(10):893. PubMed ID: 11674894 [No Abstract] [Full Text] [Related]
8. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations]. Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161 [No Abstract] [Full Text] [Related]
9. The truth about oral contraceptives and venous thromboembolism. Shulman LP; Goldzieher JW J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030 [TBL] [Abstract][Full Text] [Related]
10. Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components. Jick SS; Myers MW; Jick H Lancet; 1999 Jul; 354(9175):302-3. PubMed ID: 10440310 [TBL] [Abstract][Full Text] [Related]
11. [Third generation oral contraceptives and risk of venous thrombosis--the English lesson]. Sørensen MB Ugeskr Laeger; 2002 Apr; 164(18):2418; author reply 2418-9. PubMed ID: 12024851 [No Abstract] [Full Text] [Related]
12. Cerebral venous thrombosis as a complication of oral contraceptive use in a 15-year-old patient: a case report. Hill LW; Hindelang FM J La State Med Soc; 2007; 159(4):195, 197. PubMed ID: 17987956 [TBL] [Abstract][Full Text] [Related]
13. Third generation oral contraceptives. Skegg DC BMJ; 2000 Jul; 321(7255):190-1. PubMed ID: 10903631 [No Abstract] [Full Text] [Related]
14. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Jick SS; Kaye JA; Russmann S; Jick H Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485 [TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives. Med Lett Drugs Ther; 2000 May; 42(1078):42-4. PubMed ID: 10847115 [No Abstract] [Full Text] [Related]
16. Risk of venous thromboembolism with third-generation oral contraceptives: A review. Weiss G Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 2):295-301. PubMed ID: 9988833 [TBL] [Abstract][Full Text] [Related]
17. Effect on stroke of different progestagens in low oestrogen dose oral contraceptives. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Poulter NR; Chang CL; Farley TM; Marmot MG; Meirik O Lancet; 1999 Jul; 354(9175):301-2. PubMed ID: 10440309 [TBL] [Abstract][Full Text] [Related]
19. [Sale of oral contraceptives, births and abortions prior to and after the "Marvelon issue"]. Skjeldestad FE Tidsskr Nor Laegeforen; 2000 Jan; 120(3):339-44. PubMed ID: 10827525 [TBL] [Abstract][Full Text] [Related]